Insomnia Clinical Trial
Official title:
The Effect of a Once Daily Evening Dose of Atomoxetine (ATX) on ADHD-Related Insomnia in Children and Adolescents
NCT number | NCT00252278 |
Other study ID # | 0120-05 |
Secondary ID | |
Status | Recruiting |
Phase | Phase 4 |
First received | November 9, 2005 |
Last updated | July 5, 2006 |
Start date | November 2005 |
Children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) very commonly
experience difficulty in initiating and maintaining sleep. Studies have shown that daytime
sleepiness resulting from insufficient sleep can affect attention and learning. Therefore,
treating insomnia in children with ADHD may not only improve sleep, but it could potentially
improve ADHD symptoms as well.
The main purpose of this study is to examine the effects of atomoxetine on ADHD-related
insomnia. Atomoxetine (Strattera®) is a non-stimulant drug used to treat ADHD symptoms in
both children and adults, and there is evidence that it may also have a positive effect on
sleep in children with ADHD. During the study, participants will receive either atomoxetine
or placebo for a period of four weeks. We expect that the effects of atomoxetine on sleep
will differ from those of placebo, with atomoxetine having a greater effect on improving
sleep difficulties.
Status | Recruiting |
Enrollment | 36 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 6 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Boy or girl aged 6-17 years, inclusive, and English-speaking - Meet the DSM-IV criteria for Attention-Deficit/Hyperactivity Disorder - Have sleep initiation defined by: 1. difficulty initiating or maintaining sleep that is viewed as a problem by the child or caregiver 2. sleep onset delay that is not exclusively related to direct or rebound effects of psychostimulant treatment - Have a parent or legal guardian willing to participate in the study Exclusion Criteria: - Have any other primary sleep disorder(s) (e.g. obstructive sleep apnea or periodic limb movement disorder) - Have a history of significant chronic medical (e.g. diabetes, severe asthma) or psychiatric (e.g. depression) illness - Have a history of chronic use of sedating (e.g. antihistamines) or alertness enhancing (e.g. caffeine) medications - Have a history of failure to respond to an adequate (defined as appropriate dose and adequate duration of therapy) previous trial with atomoxetine |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Rhode Island Hospital | Providence | Rhode Island |
Lead Sponsor | Collaborator |
---|---|
Rhode Island Hospital | Eli Lilly and Company |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | mean sleep onset latency | |||
Primary | parent and child-reported evening settling difficulties | |||
Secondary | night wakings, sleep duration, and sleep efficiency | |||
Secondary | daytime sleepiness | |||
Secondary | ADHD symptom improvement | |||
Secondary | executive functions and functional outcomes/quality of life |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A |